Foghorn Therapeutics Inc. Income Taxes Paid
Foghorn Therapeutics Inc. (FHTX) reported Income Taxes Paid of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-06
- Foghorn Therapeutics Inc. income taxes paid, net for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. income taxes paid, net for the quarter ending 2026-03-31 was $2.00K, a 50.00% decline year-over-year.
- Foghorn Therapeutics Inc. income taxes paid, net for the quarter ending 2025-12-31 was $1.00K, a 97.87% decline year-over-year.
- Foghorn Therapeutics Inc. income taxes paid, net for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Foghorn Therapeutics Inc. income taxes paid, net for fiscal 2025 was $9.00K, a 98.95% decline from fiscal 2024.
- Foghorn Therapeutics Inc. income taxes paid, net for fiscal 2024 was $860.00K, a 75.78% decline from fiscal 2023.
- Foghorn Therapeutics Inc. income taxes paid, net for fiscal 2023 was $3.55M.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.00K 10-Q · filed 2026-08-06 | $3.00K derived: sum of 3 quarters · filed 2026-08-06 | $3.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-07 | $3.00K derived: sum of 2 quarters · filed 2026-05-07 | $3.00K derived: sum of 3 quarters · filed 2026-05-07 | $7.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.00K derived: sum of 2 quarters · filed 2026-03-11 | $5.00K derived: sum of 3 quarters · filed 2026-08-06 | $9.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.00K derived: sum of 2 quarters · filed 2026-08-06 | $8.00K 10-Q · filed 2025-11-05 | $55.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.00K 10-Q · filed 2026-08-06 | $55.00K derived: sum of 3 quarters · filed 2026-08-06 | $114.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-07 | $51.00K derived: sum of 2 quarters · filed 2026-05-07 | $110.00K derived: sum of 3 quarters · filed 2026-05-07 | $815.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $106.00K derived: sum of 2 quarters · filed 2026-03-11 | $811.00K derived: sum of 3 quarters · filed 2026-03-11 | $860.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $764.00K derived: sum of 2 quarters · filed 2025-11-05 | $813.00K 10-Q · filed 2025-11-05 | $1.68M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $705.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $754.00K 10-Q · filed 2025-08-05 | $1.62M derived: sum of 3 quarters · filed 2025-08-05 | $2.62M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $49.00K 10-Q · filed 2025-05-14 | $914.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.91M derived: sum of 3 quarters · filed 2025-05-14 | $3.60M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $865.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.86M derived: sum of 2 quarters · filed 2025-03-06 | $3.55M derived: sum of 3 quarters · filed 2025-03-06 | $3.55M 10-K · filed 2025-03-06 |
| 2023-09-30 | $996.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $2.69M derived: sum of 2 quarters · filed 2024-11-04 | $2.69M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.69M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-06 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |